MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation ...

Icon ( ($ICLR) ) has shared an announcement. On November 12, 2025, ICON plc announced that its CEO, Barry Balfe, and CFO, Nigel Clerkin, will ...

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 ...

Discusses Discontinuation of ICoN-1 Phase III Trial for Nebulized Clofazimine in NTM Lung Disease November 9:00 ...

Dr. Harshan Lamabadusuriya started his schooling at Richmond College Galle and then spent a couple of years at S. Thomas’ ...

Icon Plc ( ($ICLR) ) has released its Q3 earnings. Here is a breakdown of the information Icon Plc presented to its investors. ICON plc, ...

Investing.com -- MannKind Corporation (NASDAQ:MNKD) stock fell 4% Monday after the company announced it would discontinue its Phase 3 ICoN-1 clinical trial for nontuberculous mycobacterial (NTM) lung ...

Martha Stewart revealed the one new title she wants to add to her resume in a recent post shared on Instagram on Nov. 6, two ...

Two Smith College alums—author and feminist icon Gloria Steinem ’56 and lawyer and civil rights advocate Deborah N. Archer ...

When Wilson Isidor started Sunderland’s first Premier League game of the new campaign on the bench, nobody really batted an ...

One in five people will develop dementia in their lifetime, but there are early signs that there could be a cure or treatment for the disease in the future.

Jamie Roberts will be a feature on television screens throughout November, working for TNT Sports as part of their autumn ...